Ways to Enhance Neuromodulation in Parkinsonism
Episode 101, Nov 03, 2023, 10:00 AM
Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, Alfonso Fasano, MD, PhD, professor of neurology at the University of Toronto and staff neurologist at Toronto Western Hospital, who spoke on the topic of neuromodulation in Parkinson disease and the potential targets clinicians should be learning about. He discussed the specific patient profiles who fit for neuromodulation, ways to improve this type of personalized medicine, and the needed research in this patient population going forward.
Looking for more movement disorder discussion? Check out the NeurologyLive® Movement Disorder clinical focus page.
Episode Breakdown:
In this episode, Alfonso Fasano, MD, PhD, professor of neurology at the University of Toronto and staff neurologist at Toronto Western Hospital, who spoke on the topic of neuromodulation in Parkinson disease and the potential targets clinicians should be learning about. He discussed the specific patient profiles who fit for neuromodulation, ways to improve this type of personalized medicine, and the needed research in this patient population going forward.
Looking for more movement disorder discussion? Check out the NeurologyLive® Movement Disorder clinical focus page.
Episode Breakdown:
- 1:10 – Overview of MDS presentation
- 2:40 – Reasons for complexities with freezing in parkinsonism
- 4:35 – Aspects of deep brain stimulation care that need improvement
- 7:00 – Neurology News Minute
- 9:15 – Promising neuromodulation targets in the brain
- 12:35 – Finding optimal candidates for specific neurosurgery procedures
- 18:50 – Future research of neuromodulation in Parkinson disease
This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com.
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
Eisai Plans to Submit BLA for Subcutaneous Lecanemab After Findings Show Promising Results
FDA Approves Vamorolone as a Treatment for Duchenne Muscular Dystrophy
SRP-9001 Fails to Meet Primary End Point in Phase 3 EMBARK Study
Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.